phenyl N-(3-hydroxyphenyl)carbamate | 62380-38-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: phenyl N-(3-hydroxyphenyl)carbamate
• 英文别名: Phenyl (3-hydroxyphenyl)carbamate
• CAS: 62380-38-5
• 化学式: C₁₃H₁₁NO₃
• 分子量: 229.235
• InChiKey: RRDSAHIPJWLLMN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  phenyl N-(3-hydroxyphenyl)carbamate 在 硫酸 、 N,N-二异丙基乙胺 作用下， 以 四氢呋喃 为溶剂， 反应 2.0h， 生成 7-N-(phenoxycarbonyl)amino-4-(acetylthio)methylcoumarin
  参考文献：
  名称：

  On-Bead Fluorescence Assay for Serine/Threonine Kinases

  摘要：

  [GRAPHIC]A novel fluorescence-based assay for serine/threonine kinases is described. Base-mediated beta-elimination of the phosphate moiety and the Michael addition of a thiol-containing fluorescent molecule allows convenient and efficient detection of the enzyme activity. This approach may be broadly applicable to various serine/threonine kinases.

  DOI：

  10.1021/ol052125k
• 作为产物：
  描述：

  氯甲酸苯酯 、 3-氨基苯酚 在 碳酸氢钠 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 0.08h， 以91%的产率得到phenyl N-(3-hydroxyphenyl)carbamate
  参考文献：
  名称：

  通过氨基甲酸苯酯由相应的胺和肼制备取代的氨基脲

  摘要：

  开发了一种简单的合成方法，用于将胺和肼转化为取代的氨基脲。所需的胺和氯甲酸苯酯之间最初的缩合成氨基甲酸苯酯，然后在碱性条件下加入肼。该反应可耐受各种官能团，条件温和，收率高。

  DOI：

  10.1016/j.tetlet.2014.01.052

文献信息

• [EN] ISOINDOLINONE COMPOUNDS<br/>[FR] COMPOSÉS D'ISO-INDOLINONE
  申请人：MONTE ROSA THERAPEUTICS

  公开号：WO2021069705A1

  公开（公告）日：2021-04-15

  Disclosed herein is a compound or pharmaceutically acceptable salts or stereoisomers thereof of of formula I wherein X1 is linear or branched C1-6 alkyl, C3-6 cycloalkyl, -C1-6 alkyl C3-6 cycloalkyl, C6-10 aryl, 5-10 membered heteroaryl, C1-6 alkyl C6-10 aryl, C1-6 alkyl 5-10 membered heteroaryl, wherein X1 is unsubstituted or substituted with one or more of halogen, linear or branched C1-6 alkyl, linear or branched C1-6 heteroalkyl, CF3, CHF2, -O-CHF2, -O-(CH2)2-OMe, OCF3, C1-6 alkylamino, -CN, -N(H)C(O)-C1- 6alkyl, -OC(O)-C1-6alkyl, -OC(O)-C1-4alkylamino, -C(O)O-C1-6alkyl, -COOH, - CHO, -C1-6alkylC(O)OH, -C1-6alkylC(O)O-C1-6alkyl, NH2, C1-6 alkoxy or C1-6 alkylhydroxy; X2 is hydrogen, C6-10 aryl, 5-10 membered heteroaryl, -O-(5-10 membered heteroaryl), 4-8 membered heterocycloalkyl, C1-4 alkyl 4-8 membered heterocycloalkyl, -O-(4-8 membered heterocycloalkyl), -O-C1-4 alkyl-(4-8 membered heterocycloalkyl), -OC(O)-C1-4alkyl-4-8 membered heterocycloalkyl or C6 aryloxy, wherein X2 is unsubstituted or substituted with one or more of linear or branched C1-6 alkyl, NH2, NMe2 or 5-6 membered heterocycloalkyl; n is 0, 1 or 2.

  本公开涉及一种化合物或药用可接受盐或其立体异构体，其化学式为I，其中X1为直链或支链的C1-6烷基，C3-6环烷基，-C1-6烷基C3-6环烷基，C6-10芳基，5-10成员杂芳基，C1-6烷基C6-10芳基，C1-6烷基5-10成员杂芳基，其中X1未取代或取代为一个或多个卤素，直链或支链的C1-6烷基，直链或支链的C1-6杂烷基，CF3，CHF2，-O-CHF2，-O-(CH2)2-OMe，OCF3，C1-6烷基氨基，-CN，-N(H)C(O)-C1-6烷基，-OC(O)-C1-6烷基，-OC(O)-C1-4烷基氨基，-C(O)O-C1-6烷基，-COOH，-CHO，-C1-6烷基C(O)OH，-C1-6烷基C(O)O-C1-6烷基，NH2，C1-6烷氧基或C1-6烷基羟基；X2为氢，C6-10芳基，5-10成员杂芳基，-O-(5-10成员杂芳基)，4-8成员杂环烷基，C1-4烷基4-8成员杂环烷基，-O-(4-8成员杂环烷基)，-O-C1-4烷基-(4-8成员杂环烷基)，-OC(O)-C1-4烷基-4-8成员杂环烷基或C6芳氧基，其中X2未取代或取代为一个或多个直链或支链的C1-6烷基，NH2，NMe2或5-6成员杂环烷基；n为0、1或2。
• ADDITIVE COMPOSITION FOR CULTURE MEDIUM, ADDITIVE COMPOUND FOR CULTURE MEDIUM, AND METHOD FOR CULTURE OF CELLS OR TISSUE USING SAME
  申请人：NISSAN CHEMICAL CORPORATION

  公开号：US20200165194A1

  公开（公告）日：2020-05-28

  The present invention provides a medium additive composition containing a compound represented by the following formula (I), or a salt thereof: wherein each symbol is as defined in the DESCRIPTION.}

  本发明提供一种含有由以下式（I）所表示的化合物或其盐的介质添加剂组合物： 其中每个符号如描述中所定义。}
• 2-Benzopyranone derivatives, process for their production, their use as
  申请人：Troponwerke Dinklage & Co.

  公开号：US04144336A1

  公开（公告）日：1979-03-13

  Novel 2-benzopyranone compounds of the formula ##STR1## wherein X is a 3,4,5-trimethoxybenzoyl group or a 3,4,5-trimethoxycinnamoyl group; and each R individually is selected from the group consisting of alkylamino and dialkylamino in which one carbon atom in the alkyl moiety may be replaced by an oxygen atom and one hydrogen atom may be replaced by a hydroxyl group which may in turn be esterified with a 3,4,5-trimethoxybenzoyl or 3,4,5-trimethoxycinnamoyl group; amino substituted once or twice by alkenyl, aralkyl, or cycloalkyl; or a 4- to 7-membered N-containing heterocyclic ring linked through a nitrogen atom and which contains up to 3 hetero atoms, which heterocyclic ring may be substituted by phenyl, alkyl or hydroxyalkyl, wherein the hydroxy group may be esterified by a 3,4,5-trimethoxy benzoyl or 3,4,5-trimethoxy cinnamoyl group; Or a salt of each compound with a physiologically acceptable acid; possess outstanding activity as coronary dilators. Processes for producing such compounds are also disclosed.

  化合物的结构式如下：##STR1## 其中 X 是3,4,5-三甲氧基苯甲酰基或3,4,5-三甲氧基肉桂酰基；每个 R 从以下组中独立选择：烷基氨基和二烷基氨基，其中烷基部分中的一个碳原子可被氧原子取代，一个氢原子可被羟基取代，并且羟基可能被3,4,5-三甲氧基苯甲酰基或3,4,5-三甲氧基肉桂酰基酰化；氨基被烯基、芳基烷基或环烷基取代一次或两次；或者是通过氮原子连接的4-到7-成员含氮杂环，其中含有最多3个杂原子，这种杂环可能被苯基、烷基或羟基烷基取代，羟基可能被3,4,5-三甲氧基苯甲酰基或3,4,5-三甲氧基肉桂酰基酰化；或者是每种化合物与生理上可接受的酸的盐；具有出色的冠脉扩张活性。还披露了制备这种化合物的方法。
• Coumarin-based fluorescent sensors for zinc(II) and hypochlorite
  作者：Margaret L. Aulsebrook、Bim Graham、Michael R. Grace、Kellie L. Tuck

  DOI：10.1080/10610278.2015.1077958

  日期：2015.12.2

  One sensor features a di(2-picoyl)amine metal ion-binding moiety that allows for selective detection of Zn2+ ions over other common cations in aqueous solution, with the sensor exhibiting a 5.4-fold increase in fluorescence upon Zn2+ binding (limit of detection = 26 nM). The second sensor incorporates an aminophenyl group designed to react with highly reactive oxygen species (hROS). This sensor reacts

  通过对常见的 7-氨基香豆素前体进行功能化，设计并合成了两种新的荧光化学传感器。一种传感器具有二（2-皮酰基）胺金属离子结合部分，允许选择性检测 Zn2+ 离子而不是水溶液中的其他常见阳离子，该传感器在 Zn2+ 结合时表现出 5.4 倍的荧光增加（检测限） = 26 纳米）。第二个传感器包含一个氨基苯基，旨在与高活性氧 (hROS) 反应。该传感器优先于其他 ROS 与 ClO− 反应，在添加 150 当量的 ClO− 后，荧光增加 27 倍（检测限 = 2 μM）。
• 9-aminoacridine derivatives and process for the preparation thereof
  申请人：Samjin Pharmaceutical Co., Ltd.

  公开号：US20020111491A1

  公开（公告）日：2002-08-15

  The present invention relates to new 9-aminoacridine derivatives of general formula (I), wherein A is hydrogen or (II) (wherein X is oxygen or sulfur, R 1 , R 2 , R 3 , R 4 and R 5 are independently hydrogen, halogen, nitro, amino, hydroxy, C 1 -C 4 lower alkylhydroxy, C 1 -C 4 lower alkylamino, C 1 -C 8 alkyl, C 1 -C 4 lower alkoxy or C 1 -C 4 lower alkyloxycarbonyl and m and n are independently an integer of 0, 1 or 2), R 6 , R 7 , R 8 and R 9 are independently C 1 -C 8 alkyl or C 1 -C 4 lower alkoxy, and Y is hydrogen, amino, -N═CHR′(wherein R′ is hydrogen, benzyl, C 1 -C 8 alkyl or C 1 -C 6 lower alkylamino), (III) (wherein R″ is hydrogen, benzyl, C 1 -C 8 alkyl or C 1 -C 6 lower alkylamino, and R′″ is hydrogen, benzyl, C 1 -C 8 alkyl or amino protecting group) or (IV) (wherein, X is as defined above, R 1 ′, R 2 ′, R 3 ′, R 4 ′ and R 5 ′ are independently hydrogen, halogen, nitro, amino, hydroxy, C 1 -C 4 lower alkylhydroxy, C 1 -C 4 lower alkylamino, C 1 -C 8 alkyl, C 1 -C 4 lower alkoxy or C 1 -C 4 lower alkylcarboxy, and q and r are independently an integer of 0, 1 or 2) or its pharmaceutically acceptable salt, and process for the preparation thereof.

  本发明涉及通式（I）的新9-氨基蒽衍生物，其中A为氢或（II）（其中X为氧或硫，R1、R2、R3、R4和R5独立地为氢、卤素、硝基、氨基、羟基、C1-C4较低烷基羟基、C1-C4较低烷基氨基、C1-C8烷基、C1-C4较低烷氧基或C1-C4较低烷氧羰基，m和n独立地为0、1或2的整数），R6、R7、R8和R9独立地为C1-C8烷基或C1-C4较低烷氧基，Y为氢、氨基、-N═CHR′（其中R′为氢、苄基、C1-C8烷基或C1-C6较低烷基氨基）、（III）（其中R″为氢、苄基、C1-C8烷基或C1-C6较低烷基氨基，R′″为氢、苄基、C1-C8烷基或氨基保护基）或（IV）（其中，X如上定义，R1′、R2′、R3′、R4′和R5′独立地为氢、卤素、硝基、氨基、羟基、C1-C4较低烷基羟基、C1-C4较低烷基氨基、C1-C8烷基、C1-C4较低烷氧基或C1-C4较低烷基羧基，q和r独立地为0、1或2）或其药学上可接受的盐，以及其制备方法。